Orange backs French life-sciences AI startup Biolevate
Orange has invested in French health-tech startup Biolevate through its venture arm, Orange Ventures, as part of a EUR 30 million financing round co-led with Raise France. The investment, which also saw participation from Station F, EQT Ventures and MGHIF, is designed to help Biolevate grow its scientific and regulatory workflow automation platform as well as its international expansion.